New obesity drug cut weight by 58 pounds in a trial, the most effective yet
Retatrutide, Eli Lilly’s innovative “triple g” drug, is setting new standards in the fight against obesity.
Related Articles
Buried Deep in a Huge New Mall, There’s a Sinister Experience I Should Hate. I Kind of Loved It.
Are wave pools ruining surfing—or do they solve another kind of problem?
Shocking video shows how head transplant surgery could work
Uploaded by the company, BrainBridge, the prototype could be be ready to perform the groundbreaking medical operation in as little as eight years.
Plant-Based Seafood vs. Conventional Seafood
Take a deeper dive into the growing seafood alternative category and how it compares to real fish and shellfish.
Mediterranean Diet Could Be a Stress-Buster, Study Finds
THURSDAY, May 16, 2024 (HealthDay News) — The Mediterranean diet has already been shown to be great for a person’s physical health, but new research…
Scientists use generative AI to answer complex questions in physics
Researchers used generative AI to develop a physics-informed technique to classify phase transitions in materials or physical systems that is much more efficient than existing…
Nearly half of all cancer cases are linked to obesity
Study finds excess weight could be fuelling more than 30 types of the disease
How Blockchain and AI Complement Each Other
The integration of blockchain and AI can be promising. Here is how both can complement each other and offer help in every industry.
An Explosion of Food Is Medicine Research Could Change Health Care
This Medical News article discusses research initiatives to support produce prescriptions and other “food is medicine” nutrition programs in health care settings.
New Genetic Form of Alzheimer’s Identified in People With Common Risk Factor
This could change diagnosis and treatment.
The Future Is Nearer with Ray Kurzweil
In his 2005 book, The Singularity Is Near: When Humans Transcend Biology, Ray Kurzweil made the bold prediction that AI would expand human intelligence exponentially,…